Furthermore, bisphosphonates can also reduce RANKL expression in osteoblasts and increase osteoprotegerin (OPG) expression to exert anti-osteoporosis effects (Viereck et al., 2002; Pan et al., 2004). This evidence concerns the gene TNFRSF11B and osteoporosis.